United States · FDA National Drug Code directory
Cetirizine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-402_538948d8-34aa-4460-8d66-ee8fcf4c60ab
- Product NDC
- 16571-402
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091001
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (16571-402-10) · 16571-402-10
- 300 TABLET in 1 BOTTLE (16571-402-30) · 16571-402-30
- 500 TABLET in 1 BOTTLE (16571-402-50) · 16571-402-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →